Global Fetal Bovine Serum Market 2024-2028

Global Fetal Bovine Serum Market 2024-2028

The fetal bovine serum market is forecasted to grow by USD 294.16 mn during 2023-2028, accelerating at a CAGR of 5.25% during the forecast period. The report on the fetal bovine serum market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising adoption of stem cell applications, the increasing prevalence of chronic diseases, and livestock industry growth.

Technavio's fetal bovine serum market is segmented as below:

By Application

• Biopharmaceuticals
• Human and animal vaccine
• Others

By End-user

• Pharmaceutical and biopharmaceutical companies
• Contract research organization
• Academic and research organization

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing application in cell-based pharmaceutical research as one of the prime reasons driving the fetal bovine serum market growth during the next few years. Also, increased focus on disease management and the growing adoption of preventive care will lead to sizable demand in the market.

The report on the fetal bovine serum market covers the following areas:

• Fetal bovine serum market sizing
• Fetal bovine serum market forecast
• Fetal bovine serum market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fetal bovine serum market vendors that include Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu Holdings Inc., Merck KGaA, MP Biomedicals Inc., Nucleus Biologics, PAN Biotech, Rocky Mountain Biologicals, Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., Tissue Culture Biologicals, and Celtic Molecular Diagnostics. Also, the fetal bovine serum market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.